Andrew Oxtoby - Chief Commercial Officer, Aimmune Therapeutics, Inc

As of October 14, 2020


Andrew Oxtoby Net Worth

  • Owns at least 25,015 units of Aimmune Therapeutics, Inc stock
  • Sold an estimated value of $987.34K in the last year at Aimmune Therapeutics, Inc

Andrew Oxtoby Trading

  • Largest purchase of shares was 3,000 units , worth over $44.27K on March 17, 2020
  • In total has made about 7 transactions over a year
  • Usually trades in March, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Andrew Oxtoby Mailing Address

  • Mailing address is 8000 Marina Boulevard Suite 300 Brisbane CA 94005 CA

Aimmune Therapeutics, Inc Insider Trading

  • The most recent transaction was 54,117,287 units bought on October 15, 2020 by Societe Des Produits Nestle S.A. Claudio Kuoni worth over $1.87B
  • In the last 5 years, insiders at Aimmune Therapeutics, Inc sold an estimated value of $72.67M and bought an estimated value of $2.52B
  • The most active traders are Douglas T Sheehy, See Remarks,  Daniel C. Adelman, Chief Medical Officer,  and Eric Bjerkholt, Chief Financial Officer
  • Insider trading is most common in May, with the busiest year in 2020

Aimmune Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1